发明名称 EMULSION STABILIZER
摘要 <p>It is intended to provide a medicinal composition having a high biological availability and a process for producing the same which comprises dispersing a drug component in two or more surfactants (for example, surfactants belonging to the same series such as a long-chain fatty acid glyceride having a long-chain polyoxyethylene in its hydrophilic group with a medium-chain fatty acid glyceride having a short-chain polyoxyethylene in its hydrophilic group), adding a small amount of water thereto to give a semisolid or liquid medicinal composition in the form of a microemulsion, and producing an oral preparation such as capsules by using the same so as to form and sustaina stable microemulsion containing the drug component (in particular, a hardly water-soluble drug component) in the digestive tract.</p>
申请公布号 WO2005089714(A1) 申请公布日期 2005.09.29
申请号 WO2005JP05238 申请日期 2005.03.23
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED;YOSHINARI, TOMOHIRO 发明人 YOSHINARI, TOMOHIRO
分类号 A61K9/06;A61K9/08;A61K9/107;A61K9/48;A61K31/4178;A61K45/00;A61K47/34;A61P1/04;A61P1/14;A61P1/18;A61P3/10;A61P7/00;A61P7/04;A61P9/06;A61P9/10;A61P9/12;A61P11/06;A61P11/08;A61P13/12;A61P15/00;A61P17/00;A61P17/02;A61P17/06;A61P17/16;A61P19/02;A61P19/08;A61P19/10;A61P25/00;A61P25/02;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/24;A61P25/28;A61P25/32;A61P27/02;A61P27/16;A61P29/00;A61P31/04;A61P31/06;A61P31/10;A61P31/12;A61P31/16;A61P31/18;A61P31/22;A61P35/00;A61P37/00;A61P37/02;A61P37/06;A61P37/08;A61P43/00;C07D403/12;(IPC1-7):A61K9/06;A61K31/417 主分类号 A61K9/06
代理机构 代理人
主权项
地址